CUSIP: 018119107
Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,400,485
-
Share change
-
+14,597,953
-
Total reported value
-
$168,409,462
-
Price per share
-
$10.06
-
Number of holders
-
40
-
Value change
-
+$140,216,462
-
Number of buys
-
38
Quarterly Holders Quick Answers
What is CUSIP 018119107?
CUSIP 018119107 identifies ALNAQ - ALLENA PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 018119107:
Institutional Holders of ALLENA PHARMACEUTICALS INC - COM (ALNAQ) as of Q4 2017
As of 31 Dec 2017,
ALLENA PHARMACEUTICALS INC - COM (ALNAQ) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,400,485 shares.
The largest 10 holders included
FRAZIER MANAGEMENT LLC, TRV GP II, LLC, FMR LLC, Deer VII & Co. Ltd., Partner Fund Management, L.P., Pharmstandard International S.A., WELLINGTON MANAGEMENT GROUP LLP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Partner Investment Management, L.P., and MORGAN STANLEY.
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.